Disability Tax Credit and Benefits for Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)


CIDP is a neurological disease that is shown by weaknesses and issues with sensory functions in both the legs and the arms. The disorder is fairly common, and it occurs in young adults, as well as in men more so than in women. It presents as numbness and tingling, before developing into the weaknesses of the arms and legs. Plus, CIDP is closely related to its similarly-abled disorder, Guillain-Barry Syndrome, and is typically known as the chronic counterpart of the acute disorder.

CIDP cannot be cured, but its symptoms can be treated so that people who experience the disorder can live a relatively normal and stable life, even while dealing with issues related to the disease throughout their lives.


CIDP is caused by damage to the myelin sheath, which is a fatty covering, which wraps around and protect nerve fibers throughout the body. When the myelin sheath is damaged in this way, nerve fibers are exposed and people become susceptible to nerve damage throughout their body as a result.

It is a neurological disorder, meaning its causes can seriously affect many normal day to day bodily functions, including movement, mobility, and dexterity issues, and people dealing with CIDP often undergo significant physical problems and difficulties as they deal with the disorder.


CIDP can present as many different symptoms, including tingling and numbness, which typically begins in the toes and fingers, and works its way across the arms and legs over time. Additionally, CIDP involves weakness of the arms and legs in an unexpected and often strong fashion.

Other symptoms include the loss of deep tendon reflexes, abnormal fatigue among typically young and active people, and abnormal sensations throughout the body that are mysteriously reported without a cause.

CIDP typically involves young men, and young adults, and affects men more so than it does women, though women are also affected, too. People who are affected by CIDP have the opportunity to live a normal life, but treatment can be followed with relapses when gene therapy does not work permanently.

Nevertheless, the prognosis for CIDP varies widely among different patients, as the medical community uses a variety of cutting edge gene therapy and plasma treatments to regenerate genes and improve the prognosis for people involved with the disorder. Patients can expect to live a full, fulfilling life while under care.